Institutional Investor, in a new survey of corporate social responsibility, takes the pharmaceutical industry to task. Pfizer, in particular, was singled out for shutting down public outreach efforts when company news turned sour last year. “The company has stopped communicating effectively,” Institutional Investor reports.